v3.26.1
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock and additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2024   11,155,528    
Balance at beginning of period at Dec. 31, 2024 $ 252,493 $ 71,944 $ 222,823 $ (42,274)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 15,140   15,140  
Net unrealized (loss) gain on securities available for sale, net of taxes 5,434     5,434
Net unrealized (loss) gain on securities transferred from available for sale to held to maturity, net of tax (13)     (13)
Net unrealized (loss) gain on hedging derivative instruments, net of tax (73)     (73)
Comprehensive income 20,488   15,140 5,348
Cash dividends declared (8,177)   (8,177)  
Equity compensation expense 510 $ 510    
Payment to repurchase common stock (in shares)   (11,434)    
Payment to repurchase common stock (275)   (275)  
Issuance of restricted stock (in shares)   43,297    
Proceeds from sale of common stock (in shares)   18,470    
Proceeds from sale of common stock $ 453 $ 453    
Ending balance (in shares) at Jun. 30, 2025 11,205,861 11,205,861    
Balance at end of period at Jun. 30, 2025 $ 265,492 $ 72,907 229,511 (36,926)
Beginning balance (in shares) at Mar. 31, 2025   11,196,881    
Balance at beginning of period at Mar. 31, 2025 259,681 $ 72,467 225,592 (38,378)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 8,063   8,063  
Net unrealized (loss) gain on securities available for sale, net of taxes 1,465     1,465
Net unrealized (loss) gain on securities transferred from available for sale to held to maturity, net of tax (15)     (15)
Net unrealized (loss) gain on hedging derivative instruments, net of tax 2     2
Comprehensive income 9,515   8,063 1,452
Cash dividends declared (4,146)   (4,146)  
Equity compensation expense 212 $ 212    
Payment to repurchase common stock (in shares)   (650)    
Payment to repurchase common stock 2   2  
Proceeds from sale of common stock (in shares)   9,630    
Proceeds from sale of common stock $ 228 $ 228    
Ending balance (in shares) at Jun. 30, 2025 11,205,861 11,205,861    
Balance at end of period at Jun. 30, 2025 $ 265,492 $ 72,907 229,511 (36,926)
Beginning balance (in shares) at Dec. 31, 2025 11,222,363 11,222,363    
Balance at beginning of period at Dec. 31, 2025 $ 283,143 $ 73,826 240,456 (31,139)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 18,553   18,553  
Net unrealized (loss) gain on securities available for sale, net of taxes (1,103)     (1,103)
Net unrealized (loss) gain on securities transferred from available for sale to held to maturity, net of tax 6     6
Net unrealized (loss) gain on hedging derivative instruments, net of tax 0      
Comprehensive income 17,456   18,553 (1,097)
Cash dividends declared (8,456)   (8,456)  
Equity compensation expense 612 $ 612    
Payment to repurchase common stock (in shares)   (10,906)    
Payment to repurchase common stock (299)   (299)  
Issuance of restricted stock (in shares)   49,539    
Proceeds from sale of common stock (in shares)   17,781    
Proceeds from sale of common stock $ 504 $ 504    
Ending balance (in shares) at Jun. 30, 2026 11,278,777 11,278,777    
Balance at end of period at Jun. 30, 2026 $ 292,960 $ 74,942 250,254 (32,236)
Beginning balance (in shares) at Mar. 31, 2026   11,271,014    
Balance at beginning of period at Mar. 31, 2026 286,784 $ 74,368 245,001 (32,585)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 9,560   9,560  
Net unrealized (loss) gain on securities available for sale, net of taxes 346     346
Net unrealized (loss) gain on securities transferred from available for sale to held to maturity, net of tax 3     3
Net unrealized (loss) gain on hedging derivative instruments, net of tax 0      
Comprehensive income 9,909   9,560 349
Cash dividends declared (4,286)   (4,286)  
Equity compensation expense 306 $ 306    
Payment to repurchase common stock (in shares)   (729)    
Payment to repurchase common stock (21)   (21)  
Issuance of restricted stock (in shares)   (750)    
Proceeds from sale of common stock (in shares)   9,242    
Proceeds from sale of common stock $ 268 $ 268    
Ending balance (in shares) at Jun. 30, 2026 11,278,777 11,278,777    
Balance at end of period at Jun. 30, 2026 $ 292,960 $ 74,942 $ 250,254 $ (32,236)